-
1
-
-
0004754796
-
Interleukin-2: Clinical applications
-
Lotze M.T. Rosenberg S.A. Interleukin-2: Clinical applications De Vita V.T. Jr Hellman S. Rosenberg S.A. Biologic Therapy of Cancer 1992 JB Lippincott Company Philadelphia 159 177
-
(1992)
, pp. 159-177
-
-
Lotze, M.T.1
Rosenberg, S.A.2
-
2
-
-
0027478902
-
Interleukin 2 therapy: Current role in surgical oncological practice
-
Heys S.D. Franks C.R. Eremin O. Interleukin 2 therapy: Current role in surgical oncological practice Br J Surg 80 1993 155 162
-
(1993)
Br J Surg
, vol.80
, pp. 155-162
-
-
Heys, S.D.1
Franks, C.R.2
Eremin, O.3
-
3
-
-
85114550747
-
Biologic therapy with interleukin-2; Preclinical studies
-
Lotze M.T. Biologic therapy with interleukin-2; Preclinical studies De Vita V.T. Jr Hellman S. Rosenberg S.A. Biologic Therapy of Cancer 1995 JB Lippincott Company Philadelphia
-
(1995)
-
-
Lotze, M.T.1
-
4
-
-
0024426529
-
Experience with the use of high dose interleukin-2 in the treatment of 652 cancer patients
-
Rosenberg S.A. Lotze M.T. Yang J.C. Experience with the use of high dose interleukin-2 in the treatment of 652 cancer patients Ann Surg 210 1989 474 485
-
(1989)
Ann Surg
, vol.210
, pp. 474-485
-
-
Rosenberg, S.A.1
Lotze, M.T.2
Yang, J.C.3
-
5
-
-
0028266553
-
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2
-
Rosenberg S.A. Yang J.C. Topalian S.L. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high dose bolus interleukin-2 JAMA 271 1994 907 913
-
(1994)
JAMA
, vol.271
, pp. 907-913
-
-
Rosenberg, S.A.1
Yang, J.C.2
Topalian, S.L.3
-
6
-
-
0028106484
-
Randomised comparison of high dose and low dose intravenous interleukin-2 for the therapy of metastatic renal cell cancer An interim report
-
Yang J.C. Topalian S.L. Parkinson D. Randomised comparison of high dose and low dose intravenous interleukin-2 for the therapy of metastatic renal cell cancer An interim report J Clin Oncol 12 1994 1572 1576
-
(1994)
J Clin Oncol
, vol.12
, pp. 1572-1576
-
-
Yang, J.C.1
Topalian, S.L.2
Parkinson, D.3
-
7
-
-
0022871958
-
Clinical effects and toxicity of interleukin-2 in patients with cancer
-
Lotze M.T. Matory Y.L. Rayner A.A. Clinical effects and toxicity of interleukin-2 in patients with cancer Cancer 58 1986 2764 2772
-
(1986)
Cancer
, vol.58
, pp. 2764-2772
-
-
Lotze, M.T.1
Matory, Y.L.2
Rayner, A.A.3
-
8
-
-
0022534622
-
Extravasation cf intravascular fluid mediated by the systemic administration of recombinant interleukin-2
-
Rosenstein M. Ettinghausen S.E. Rosenberg S.A. Extravasation cf intravascular fluid mediated by the systemic administration of recombinant interleukin-2 J Immunol 137 1986 1735 1742
-
(1986)
J Immunol
, vol.137
, pp. 1735-1742
-
-
Rosenstein, M.1
Ettinghausen, S.E.2
Rosenberg, S.A.3
-
9
-
-
0026657879
-
Bilateral carpal tunnel syndrome associated with interleukin 2 therapy
-
Heys S.D. Mills K.L.G. Ermin O. Bilateral carpal tunnel syndrome associated with interleukin 2 therapy Post Grad Med J 68 1992 587 588
-
(1992)
Post Grad Med J
, vol.68
, pp. 587-588
-
-
Heys, S.D.1
Mills, K.L.G.2
Ermin, O.3
|